A peanut patch vaccine is the newest option being studied for children with severe allergy to<\/p>\n
peanuts.<\/p>\n
The two types of \u201cvaccine\u201d that have received the greatest study are oral immunotherapy (OIT), and<\/p>\n
sublingual immune therapy (SLIT). Both approaches are flawed and thus have not been approved by the<\/p>\n
FDA.<\/p>\n
Oral therapy provides the best results in terms of vaccine protection against peanut exposure, but it<\/p>\n
has an intolerably high frequency of side effects. Sublingual therapy is less prone to side effects, but,<\/p>\n
unfortunately, does not provide very good vaccine protection.<\/p>\n
The new approach: epicutaneous immunotherapy (EPIT) seems to be the answer. It provides an<\/p>\n
excellent level of protection with few side effects.<\/p>\n
The peanut extract is administered by a patch worn on the skin. The dosage is gradually increased by<\/p>\n
increasing the length of time the patch is in place.<\/p>\n","protected":false},"excerpt":{"rendered":"
A peanut patch vaccine is the newest option being studied for children with severe allergy to peanuts. The two types of \u201cvaccine\u201d that have received the greatest study are oral immunotherapy (OIT), and sublingual immune therapy (SLIT). Both approaches are flawed and thus have not been approved by the FDA. Oral therapy provides the best results in terms of vaccine protection against peanut exposure, but it has an intolerably high frequency of side effects. Sublingual therapy is less prone to…<\/p>\n